TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass
January 30, 2025
TNF Pharmaceuticals, a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, announced that it has initiated the first in